Live Cell Imaging Market Key Findings and Size by 2031
The Live Cell Imaging Market is expected to register a CAGR of 8.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Live Cell Imaging Market research analyzes key trends and top market players. The report also covers analysis By Product, Technology, Application, End User, and Geography.
Purpose of the ReportThe report Live Cell Imaging Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Live Cell Imaging Market Segmentation
Product- Equipment
- Kits and Reagents
- Software
- Consumables
- Fluorescence Recovery After Photobleaching
- Fluorescence Resonance Energy Transfer
- High-content Analysis
- Fluorescence In Situ Hybridization
- Others
- Drug Discovery
- Cell Biology
- Developmental Biology
- Stem Cells
- Others
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Diagnostic Laboratories
- Others
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Diagnostic Laboratories
- Others
Strategic Insights
Live Cell Imaging Market Growth Drivers- Automation and AI Enhance Imaging Precision: Improved recent trends in automation and artificial intelligence further improve imaging precision. This would be resuscitated by the continuous development of high-resolution imaging systems and increasingly state-of-the-art techniques, such as fluorescence microscopy, for more accurate cellular analysis in support of drug discovery and disease research. Therefore, researchers are focusing on real-time cellular insights that fuel global market growth driven by demand for leading-edge technologies that power their market share and transform the face of scientific research worldwide.
- Live Cell Imaging Boosts Drug Discovery: Greater adoption of this technology in drug discovery and development is one of the major drivers for the growth of the live cell imaging market. It allows the visualization of real-time cellular responses, which is one of the essential things to carry out assessments of drug efficacy and toxicity. Market analyses indicate that pharmaceutical companies have significantly invested in live cell imaging to expedite pipelines and better outcomes in treatment. As personalized medicine has gained a hold, the market size is quite expansive and allows live cell imaging to play a beneficial role in shaping the future of global healthcare developments and innovation.
- Cancer Research Drives Live Cell Imaging Demand: Live cell imaging is gaining importance in cancer studies to understand tumor growth metastasis and cellular behavior. The demand for this technique will thus go up from the monitoring of interactions between cancer cells and the microenvironment. Increasing adoption of precision oncology is encouraging market size according to market reports. Researchers are targeting these techniques to make more directed cancer therapies that greatly change market trends and bring about higher market shares across research institutes and healthcare providers worldwide.
- Personalized Medicine Expands Live Cell Imaging Role: Live cell imaging has become part of personalized medicine due to its increased application in diagnostics and therapies. Advanced imaging techniques offer individualized treatments through deeper insights into the cellular behaviors of different patients. Current market trends are dominated by adaptations through changes in the strategies of key players involving targeted therapies. SWOT analysis underlines the growth opportunity in this particular sector despite high investment costs remaining a challenge. The PEST analysis further insists that benign demographic changes will continue to support demand.
- Research Institutes Fuel Live Cell Imaging Advancements: The PESTEL/STRATEGIC FRAMEWORK: Learning and research institutes are becoming increasingly adept in making live cell imaging technologies as input for furthering research in biology and medicine. It is due to collaboration with industry leaders and state-of-the-art imaging platforms. SWOT analysis says that academic innovation is a strength while lack of proper budget is considered a weakness. According to PEST analysis, the growth factors are well-funded by the government and have strong policy support. As a result, investment in research by such institutions has implied that the key players start readjusting their market strategies towards accommodating such educational needs.
- High-Content Screening Transforms Market Dynamics: High-content screening is being increasingly adopted in the live cell imaging market because of its potential to analyze large datasets from live cell experiments. It has also transformed market dynamics where the key players are embracing HCS-based market strategies to build efficient research. Strengths are highlighted through SWOT analysis by high-throughput data acquisition despite the challenges in data interpretation. Growing government and institutional funding and demand for this application in academics and pharmaceutical sectors are thus fueling market adoption, according to PEST analysis.
- Collaborations Drive Innovation and Market Growth: Collaboration between research institutes and companies in different geographies is emerging as a crucial driver in the live cell imaging market. Competitive analysis has indicated that 38% of North American and European research centers are now collaborating on projects utilizing live cell imaging that propagate innovation and growth. This trend offers opportunities for market leaders to expand their respective presence and tailor solutions to meet collaborative research needs. Global in nature, these partnerships are reshaping the face of the industry, in particular within such growth regions as Asia-Pacific.
- 3D Imaging Solutions Spark Demand in Live Cell Imaging: High-resolution, advanced 3D imaging solutions, especially concerning complex cell structures and tissue, are in high demand within the live cell imaging market. This opens up a large opportunity for 3D-specific imaging product developing companies. The prospects of the technology are also gaining attention in Europe, where a focus on precision research is revolutionizing the overall industry scenario there.
- CRISPR Integration Revolutionizes Biological Research: The integration of live cell imaging with CRISPR gene editing is revolutionizing biological research, a significant growth opportunity. This leads to a positive competition landscape for companies investing in integration with the key geographies of Europe and Asia-Pacific.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Live Cell Imaging Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Live Cell Imaging Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies in this market are: Thermo Fisher Scientific Inc, PerkinElmer Inc, General Electric, Olympus Corporation, BioTek Instruments Inc, Molecular Devices LLC, CYTOSKELETON INC, Bruker, Nikon Instruments Inc
Key future trends in this market are - Advancements in microscopy technologies, Growth in drug discovery, Demand for real-time cell analysis
The Live Cell Imaging Market is expected to register a CAGR of 8.8% from 2023-2031.
The major factors impacting the Live Cell Imaging Market are: Technological Advancements in Imaging Systems, Rising Demand in Drug Discovery and Development, and Growing Application in Cancer Research
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Live Cell Imaging Market - By Product
1.3.2 Live Cell Imaging Market - By Technology
1.3.3 Live Cell Imaging Market - By Application
1.3.4 Live Cell Imaging Market - By End User
1.3.5 Live Cell Imaging Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVE CELL IMAGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVE CELL IMAGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIVE CELL IMAGING MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVE CELL IMAGING - GLOBAL MARKET OVERVIEW
6.2. LIVE CELL IMAGING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EQUIPMENT
7.3.1. Overview
7.3.2. Equipment Market Forecast and Analysis
7.4. KITS AND REAGENTS
7.4.1. Overview
7.4.2. Kits and Reagents Market Forecast and Analysis
7.5. SOFTWARE
7.5.1. Overview
7.5.2. Software Market Forecast and Analysis
7.6. CONSUMABLES
7.6.1. Overview
7.6.2. Consumables Market Forecast and Analysis
8. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING
8.3.1. Overview
8.3.2. Fluorescence Recovery After Photobleaching Market Forecast and Analysis
8.4. FLUORESCENCE RESONANCE ENERGY TRANSFER
8.4.1. Overview
8.4.2. Fluorescence Resonance Energy Transfer Market Forecast and Analysis
8.5. HIGH-CONTENT ANALYSIS
8.5.1. Overview
8.5.2. High-content Analysis Market Forecast and Analysis
8.6. FLUORESCENCE IN SITU HYBRIDIZATION
8.6.1. Overview
8.6.2. Fluorescence In Situ Hybridization Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DRUG DISCOVERY
9.3.1. Overview
9.3.2. Drug Discovery Market Forecast and Analysis
9.4. CELL BIOLOGY
9.4.1. Overview
9.4.2. Cell Biology Market Forecast and Analysis
9.5. DEVELOPMENTAL BIOLOGY
9.5.1. Overview
9.5.2. Developmental Biology Market Forecast and Analysis
9.6. STEM CELLS
9.6.1. Overview
9.6.2. Stem Cells Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. LIVE CELL IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
10.4. HOSPITALS
10.4.1. Overview
10.4.2. Hospitals Market Forecast and Analysis
10.5. DIAGNOSTIC LABORATORIES
10.5.1. Overview
10.5.2. Diagnostic Laboratories Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. LIVE CELL IMAGING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Live Cell Imaging Market Overview
11.1.2 North America Live Cell Imaging Market Forecasts and Analysis
11.1.3 North America Live Cell Imaging Market Forecasts and Analysis - By Product
11.1.4 North America Live Cell Imaging Market Forecasts and Analysis - By Technology
11.1.5 North America Live Cell Imaging Market Forecasts and Analysis - By Application
11.1.6 North America Live Cell Imaging Market Forecasts and Analysis - By End User
11.1.7 North America Live Cell Imaging Market Forecasts and Analysis - By Countries
11.1.7.1 United States Live Cell Imaging Market
11.1.7.1.1 United States Live Cell Imaging Market by Product
11.1.7.1.2 United States Live Cell Imaging Market by Technology
11.1.7.1.3 United States Live Cell Imaging Market by Application
11.1.7.1.4 United States Live Cell Imaging Market by End User
11.1.7.2 Canada Live Cell Imaging Market
11.1.7.2.1 Canada Live Cell Imaging Market by Product
11.1.7.2.2 Canada Live Cell Imaging Market by Technology
11.1.7.2.3 Canada Live Cell Imaging Market by Application
11.1.7.2.4 Canada Live Cell Imaging Market by End User
11.1.7.3 Mexico Live Cell Imaging Market
11.1.7.3.1 Mexico Live Cell Imaging Market by Product
11.1.7.3.2 Mexico Live Cell Imaging Market by Technology
11.1.7.3.3 Mexico Live Cell Imaging Market by Application
11.1.7.3.4 Mexico Live Cell Imaging Market by End User
11.2. EUROPE
11.2.1 Europe Live Cell Imaging Market Overview
11.2.2 Europe Live Cell Imaging Market Forecasts and Analysis
11.2.3 Europe Live Cell Imaging Market Forecasts and Analysis - By Product
11.2.4 Europe Live Cell Imaging Market Forecasts and Analysis - By Technology
11.2.5 Europe Live Cell Imaging Market Forecasts and Analysis - By Application
11.2.6 Europe Live Cell Imaging Market Forecasts and Analysis - By End User
11.2.7 Europe Live Cell Imaging Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Live Cell Imaging Market
11.2.7.1.1 Germany Live Cell Imaging Market by Product
11.2.7.1.2 Germany Live Cell Imaging Market by Technology
11.2.7.1.3 Germany Live Cell Imaging Market by Application
11.2.7.1.4 Germany Live Cell Imaging Market by End User
11.2.7.2 France Live Cell Imaging Market
11.2.7.2.1 France Live Cell Imaging Market by Product
11.2.7.2.2 France Live Cell Imaging Market by Technology
11.2.7.2.3 France Live Cell Imaging Market by Application
11.2.7.2.4 France Live Cell Imaging Market by End User
11.2.7.3 Italy Live Cell Imaging Market
11.2.7.3.1 Italy Live Cell Imaging Market by Product
11.2.7.3.2 Italy Live Cell Imaging Market by Technology
11.2.7.3.3 Italy Live Cell Imaging Market by Application
11.2.7.3.4 Italy Live Cell Imaging Market by End User
11.2.7.4 Spain Live Cell Imaging Market
11.2.7.4.1 Spain Live Cell Imaging Market by Product
11.2.7.4.2 Spain Live Cell Imaging Market by Technology
11.2.7.4.3 Spain Live Cell Imaging Market by Application
11.2.7.4.4 Spain Live Cell Imaging Market by End User
11.2.7.5 United Kingdom Live Cell Imaging Market
11.2.7.5.1 United Kingdom Live Cell Imaging Market by Product
11.2.7.5.2 United Kingdom Live Cell Imaging Market by Technology
11.2.7.5.3 United Kingdom Live Cell Imaging Market by Application
11.2.7.5.4 United Kingdom Live Cell Imaging Market by End User
11.2.7.6 Rest of Europe Live Cell Imaging Market
11.2.7.6.1 Rest of Europe Live Cell Imaging Market by Product
11.2.7.6.2 Rest of Europe Live Cell Imaging Market by Technology
11.2.7.6.3 Rest of Europe Live Cell Imaging Market by Application
11.2.7.6.4 Rest of Europe Live Cell Imaging Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Live Cell Imaging Market Overview
11.3.2 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis
11.3.3 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Live Cell Imaging Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Live Cell Imaging Market
11.3.7.1.1 Australia Live Cell Imaging Market by Product
11.3.7.1.2 Australia Live Cell Imaging Market by Technology
11.3.7.1.3 Australia Live Cell Imaging Market by Application
11.3.7.1.4 Australia Live Cell Imaging Market by End User
11.3.7.2 China Live Cell Imaging Market
11.3.7.2.1 China Live Cell Imaging Market by Product
11.3.7.2.2 China Live Cell Imaging Market by Technology
11.3.7.2.3 China Live Cell Imaging Market by Application
11.3.7.2.4 China Live Cell Imaging Market by End User
11.3.7.3 India Live Cell Imaging Market
11.3.7.3.1 India Live Cell Imaging Market by Product
11.3.7.3.2 India Live Cell Imaging Market by Technology
11.3.7.3.3 India Live Cell Imaging Market by Application
11.3.7.3.4 India Live Cell Imaging Market by End User
11.3.7.4 Japan Live Cell Imaging Market
11.3.7.4.1 Japan Live Cell Imaging Market by Product
11.3.7.4.2 Japan Live Cell Imaging Market by Technology
11.3.7.4.3 Japan Live Cell Imaging Market by Application
11.3.7.4.4 Japan Live Cell Imaging Market by End User
11.3.7.5 South Korea Live Cell Imaging Market
11.3.7.5.1 South Korea Live Cell Imaging Market by Product
11.3.7.5.2 South Korea Live Cell Imaging Market by Technology
11.3.7.5.3 South Korea Live Cell Imaging Market by Application
11.3.7.5.4 South Korea Live Cell Imaging Market by End User
11.3.7.6 Rest of Asia-Pacific Live Cell Imaging Market
11.3.7.6.1 Rest of Asia-Pacific Live Cell Imaging Market by Product
11.3.7.6.2 Rest of Asia-Pacific Live Cell Imaging Market by Technology
11.3.7.6.3 Rest of Asia-Pacific Live Cell Imaging Market by Application
11.3.7.6.4 Rest of Asia-Pacific Live Cell Imaging Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Live Cell Imaging Market Overview
11.4.2 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis
11.4.3 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Live Cell Imaging Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Live Cell Imaging Market
11.4.7.1.1 South Africa Live Cell Imaging Market by Product
11.4.7.1.2 South Africa Live Cell Imaging Market by Technology
11.4.7.1.3 South Africa Live Cell Imaging Market by Application
11.4.7.1.4 South Africa Live Cell Imaging Market by End User
11.4.7.2 Saudi Arabia Live Cell Imaging Market
11.4.7.2.1 Saudi Arabia Live Cell Imaging Market by Product
11.4.7.2.2 Saudi Arabia Live Cell Imaging Market by Technology
11.4.7.2.3 Saudi Arabia Live Cell Imaging Market by Application
11.4.7.2.4 Saudi Arabia Live Cell Imaging Market by End User
11.4.7.3 U.A.E Live Cell Imaging Market
11.4.7.3.1 U.A.E Live Cell Imaging Market by Product
11.4.7.3.2 U.A.E Live Cell Imaging Market by Technology
11.4.7.3.3 U.A.E Live Cell Imaging Market by Application
11.4.7.3.4 U.A.E Live Cell Imaging Market by End User
11.4.7.4 Rest of Middle East and Africa Live Cell Imaging Market
11.4.7.4.1 Rest of Middle East and Africa Live Cell Imaging Market by Product
11.4.7.4.2 Rest of Middle East and Africa Live Cell Imaging Market by Technology
11.4.7.4.3 Rest of Middle East and Africa Live Cell Imaging Market by Application
11.4.7.4.4 Rest of Middle East and Africa Live Cell Imaging Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Live Cell Imaging Market Overview
11.5.2 South and Central America Live Cell Imaging Market Forecasts and Analysis
11.5.3 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Product
11.5.4 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Application
11.5.6 South and Central America Live Cell Imaging Market Forecasts and Analysis - By End User
11.5.7 South and Central America Live Cell Imaging Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Live Cell Imaging Market
11.5.7.1.1 Brazil Live Cell Imaging Market by Product
11.5.7.1.2 Brazil Live Cell Imaging Market by Technology
11.5.7.1.3 Brazil Live Cell Imaging Market by Application
11.5.7.1.4 Brazil Live Cell Imaging Market by End User
11.5.7.2 Argentina Live Cell Imaging Market
11.5.7.2.1 Argentina Live Cell Imaging Market by Product
11.5.7.2.2 Argentina Live Cell Imaging Market by Technology
11.5.7.2.3 Argentina Live Cell Imaging Market by Application
11.5.7.2.4 Argentina Live Cell Imaging Market by End User
11.5.7.3 Rest of South and Central America Live Cell Imaging Market
11.5.7.3.1 Rest of South and Central America Live Cell Imaging Market by Product
11.5.7.3.2 Rest of South and Central America Live Cell Imaging Market by Technology
11.5.7.3.3 Rest of South and Central America Live Cell Imaging Market by Application
11.5.7.3.4 Rest of South and Central America Live Cell Imaging Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL LIVE CELL IMAGING MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. LIVE CELL IMAGING MARKET, KEY COMPANY PROFILES
14.1. THERMO FISHER SCIENTIFIC INC.
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PERKINELMER INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. GE HEALTHCARE
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. OLYMPUS CORPORATION
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BIOTEK INSTRUMENTS, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MOLECULAR DEVICES, LLC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CYTOSKELETON, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. BRUKER CORPORATION
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NIKON CORPORATION
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. MERCK KGAA
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Thermo Fisher Scientific Inc.
2. PerkinElmer Inc.
3. General Electric
4. Olympus Corporation
5. BioTek Instruments, Inc.
6. Molecular Devices, LLC.
7. CYTOSKELETON, INC.
8. Bruker
9. Nikon Instruments Inc.
10. Merck KGaA
11. Keyence Corporation
12. NanoLive SA
13. Sony Biotechnology Inc.
14. Phase Focus
15. Logos Biosystems (Aligned Genetics, Inc.)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For